tirzepatide drug mounjaro New Blockbuster Type 2 Medication Gets FDA Approval Mounjaro, Zepbound: Why two names

PlexusDx genetic testing identifies these patterns before you begin treatment, allowing your provider to customize your dose progression strategy from month one

antidiarrheals should be considered temporary measures while your body adapts, not long-term solutions

Renewable certification keeps you compliant with evolving FDA guidelines and latest treatment protocols

Tirzepatide promises to be a megablockbuster with a number of analysts pegging peak annual sales hitting $25 billion

These medications are just one aspect of our comprehensive treatment plans

If your first month is slower than expected, that does not automatically mean the medication is failing